0.9200USD-2.90%Mkt Cap: 10.46M USDP/E: —Last update: 2026-06-01
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is Car…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap10.46M USD
Enterprise Value10.04M USD
Revenue (TTM)—
Gross Profit-4.67M USD
Net Income (TTM)-8.23M USD
Revenue/Share—
Last Price0.9200 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.66
PEG—
EV/EBITDA-1.29
EV/Revenue—
P/S—
P/B-9.59
EPS (TTM)-0.85
EPS (Forward)-0.56
52W Range
0.84005% of range2.450
52W High2.450 USD
52W Low0.8400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-919.33%
ROA-241.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.44M USD
CapEx (TTM)7.00K USD
FCF Margin—
FCF Yield-47.24%
Net Debt-539.00K USD
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity0.59
Current Ratio0.41
Quick Ratio0.35
Book Value/Sh-0.0970 USD
Cash/Share0.0840 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 6, 2019
Splits
Last Split1:15
Split DateMay 30, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)15.50 USD
Target Range6.000 USD – 25.00 USD
# Analysts2
Ownership
Shares Out.11.37M
Float8.76M
Insiders30.04%
Institutions7.13%
Short Interest
Short Ratio0.8d
Short % Float2.58%
Short % Out.2.16%
Shares Short245.78K
Short (prev mo.)176.56K
Technical
SMA 501.122 (-18.0%)
SMA 2001.350 (-31.8%)
Beta0.55
S&P 52W Chg27.94%
Avg Vol (30d)268.75K
Avg Vol (10d)145.65K
Technical Indicators
RSI (14)39.5
MACD-0.0633
MACD Signal-0.0581
MACD Hist.-0.0052
BB Upper1.201 USD
BB Middle1.018 USD
BB Lower0.8355 USD
BB Width35.92%
ATR (14)0.0642 USD
Vol Ratio (20d)0.26x